Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California

项目2VIDA！

• 批准号: 10347120
• 负责人: Argentina Elisa Noelle Servin
• 金额: $ 67.57万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-04-23 至 2026-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10347120
• 关键词: 18 year old; 2019-nCoV; Address; Adult; Affect; African American; Area; Awareness; Behavior; Belief; Benefits and Risks; Biological Factors; COVID-19; COVID-19 intervention; COVID-19 mortality; COVID-19 vaccination; COVID-19 vaccine; California; Centers for Disease Control and Prevention (U.S.); Cessation of life; Characteristics; Client satisfaction; Color; Communities; Community Health; Community Outreach; Country; County; Data; Education; Fright; Generations; Genetic; Geographic Locations; Government; Handwashing; Health; Health Promotion; Healthcare; Home; Human Rights; Immunization; Immunization Programs; Individual; Infection; Intervention; Knowledge; Latino; Latinx; Masks; Medical; Methods; Modeling; Nature; Neighborhood Health Center; Not Hispanic or Latino; Occupations; Outcome; Participant; Perception; Phase; Policies; Population; Prevention; Preventive; Protocols documentation; Randomized Controlled Trials; Recommendation; Recording of previous events; Reporting; Research; Series; Services; Site; Social Distance; Strategic Planning; Structure; Time; Trust; United States; United States National Institutes of Health; Vaccination; Vaccines; Virus; Vulnerable Populations; World Health Organization; acceptability and feasibility; adverse outcome; base; community based participatory research; contextual factors; demographics; ethnic minority population; evidence base; experience; follow-up; health care availability; health care service utilization; health disparity; hospitalization rates; implementation intervention; improved; indicated prevention; infection rate; interest; intervention effect; intervention refinement; pandemic disease; participant retention; prevent; racial and ethnic; racial minority; racism; recruit; satisfaction; scale up; social; social exclusion; social factors; sociodemographics; standard of care; uptake; vaccine acceptance; vaccine access; vaccine hesitancy; working group

PROJECT SUMMARY As of January 2021, the World Health Organization (WHO) reports that 89 million cases of COVID-19 (SARS- CoV-2) have been confirmed and have resulted in more than 1.9 million deaths globally. Currently, the United States (U.S.) is the country with the largest number of infections and deaths due to COVID-19, with a total of 22 million infections and 373,167 deaths. Furthermore, early findings that have examined COVID-19 demographics show that racial and ethnic minorities in the U.S. are bearing a disproportionate number of COVID-19 cases and deaths irrespective of geographic region. While there's no evidence that people of color (POC) have genetic or biological factors that make them more likely to be affected by COVID-19, they are more likely to have underlying health conditions, live in multi-generational homes, live in densely populated areas, have limited access to healthcare, and have jobs that are considered essential and involve interaction with the public. All of these factors contribute to higher rates of infection and adverse outcomes due to COVID-19. Although COVID-19 preventive behaviors such as hand washing, mask wearing, and social distancing have been shown to be effective in curbing the spread of the virus, acceptance and uptake of COVID-19 vaccines will be instrumental to ending the pandemic. However, public confidence in vaccination is fragile, especially among racial and ethnic minorities. To this end, we have formed an intervention working group comprised of representatives from community and academic organizations to address challenges in COVID-19 vaccination uptake among Latinx and African American (AA) communities in Southern California by using a community-based participatory research (CBPR) approach. Project 2VIDA! (SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California), is a multilevel intervention to address individual, social, and contextual factors related to access to, and acceptance of, the COVID-19 vaccine among Latinx and AA adults (>18 years old) across six highly affected communities in Southeast San Diego. 2VIDA! seeks to implement and assess a COVID-19 vaccination protocol to increase interest and uptake of COVID-19 vaccine, provide COVID-19 vaccines in the community, and establish a model for the rapid vaccination of Latino and AA adults that could be generalizable to other highly affected communities. 2VIDA! builds on our previous CBPR efforts and centers on conducting COVID-19 community outreach and health promotion, Individual awareness and education, and linkages to medical and supportive services and offering the COVID-19 vaccine to Latinx and AA adults (>18 years old) in community health centers (CHC) and mini-vaccination stations in communities highly impacted by the pandemic in San Diego County.

项目摘要 截至2021年1月，世界卫生组织（WHO）报告说，有8900万例Covid案件（SARS- COV-2已被确认，并在全球造成超过190万人死亡。目前，曼联 州（美国）是19年感染和死亡人数数量最多的国家，总共 2200万感染和373,167人死亡。此外，已经检查了Covid-19的早期发现 人口统计表明，美国的种族和少数民族的数量不成比例 COVID-19案件和死亡，无论地理区域如何。虽然没有证据表明有色人种 （POC）具有遗传或生物学因素，使其更有可能受到Covid-19的影响，它们是 更有可能存在潜在的健康状况，生活在多代房屋中，生活在人口稠密 领域，获得医疗保健的机会有限，并且有被认为是必不可少的工作并涉及互动 与公众在一起。所有这些因素都导致感染率更高，而由于Covid-19引起的不良后果。虽然相互预防行为，例如洗手，面具戴和社交遥远的行为 已证明可以有效遏制病毒的传播，Covid-19的接受和吸收 疫苗将有助于结束大流行。但是，公众对疫苗接种的信心是脆弱的， 特别是在种族和少数民族中。为此，我们组成了一个干预工作组 由社区和学术组织的代表组成，以应对Covid-19的挑战 拉丁裔和非裔美国人（AA）社区的疫苗接种量通过使用 基于社区的参与研究（CBPR）方法。项目2VIDA！ （SARS-COV-2疫苗干预 在南加州的成年人提供），是一种多层次干预措施，可解决个人，社会和 在拉丁裔和AA成年人中获得和接受的情境因素与获得和接受有关 （> 18岁）在圣地亚哥东南部的六个受影响的六个受影响的社区。 2VIDA！寻求实施 并评估COVID-19疫苗接种方案，以增加COVID-19疫苗的利息和吸收，提供 社区中的Covid-19疫苗，并为拉丁裔和AA成人快速疫苗接种建立模型 这可能是可以推广到其他受到高度影响的社区的。 2VIDA！以我们以前的CBPR努力为基础 并以进行Covid-19社区推广和健康促进，个人意识和 教育，并与医疗和支持服务联系，并向Latinx和 社区卫生中心（CHC）和社区中的小型疫苗接种站的AA成人（> 18岁） 受圣地亚哥县大流行的影响很大。